Showing results (2541-2550 of 4,523) with videos related to
Sort By:
Pageof 453
Neurotoxicology|November 14, 2002
Parkinson's disease and related synucleinopathies are a new class of nervous system amyloidosesJohn Q Trojanowski, Virginia M Y LeeNeurotoxicology|November 14, 2002
Development of new treatments for Parkinson's disease in transgenic animal models: a role for beta-synucleinEliezer Masliah, Makoto HashimotoNeurotoxicology|November 14, 2002
Environmental factors in Parkinson's diseaseDonato A Di Monte, Mitra Lavasani, Amy B Manning-BogNeurotoxicology|November 14, 2002
Parkinson's genetics: molecular insights for the new millenniumLisa Skipper, Matt FarrerNeurotoxicology|November 14, 2002
Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotype in Parkinson's diseaseSamir N Kelada, Paola Costa-Mallen, Lucio G Costa, et al.Neurotoxicology|November 14, 2002
Conformational behavior of human alpha-synuclein is modulated by familial Parkinson's disease point mutations A30P and A53TJie Li, Vladimir N Uversky, Anthony L FinkNeurotoxicology|November 14, 2002
L-DOPA does not cause neurotoxicity in VMAT2 heterozygote knockout miceMaria E Reveron, Katerina V Savelieva, Jennifer L Tillerson, et al.Neurotoxicology|October 22, 2002
Ritonavir protects hippocampal neurons against oxidative stress-induced apoptosisWenshuai Wan, Paolo B DePetrilloNeurotoxicology|October 22, 2002
Abeta[25-35] peptide and iron promote apoptosis in lymphocytes by an oxidative stress mechanism: involvement of H2O2, caspase-3, NF-kappaB, p53 and c-JunCarlos Velez-Pardo, Gloria Garcia Ospina, Marlene Jimenez del RioNeurotoxicology|April 20, 2001
Effects of Huperzine used as pre-treatment against soman-induced seizuresL S Tonduli, G Testylier, C Masqueliez, et al.Pageof 453